Registration for a live webinar on 'Innate immunity, inflammation and cancer' is now open.
See webinar details
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Luminal Gastroenterology
-
31 min
1. Novel treatments for GI malignancies- Prof. Bert H. O'Neil
-
40 min
2. The spectrum of GERD implications for assessment and management- Prof. Eamonn M. M. Quigley
-
54 min
3. Oro-pharyngeal and esophageal motility and dysmotility- Dr. John E. Pandolfino
-
55 min
4. Eosinophilic esophagitis and other non-reflux esophageal disorders- Prof. David Katzka
-
39 min
-
17 min
-
48 min
-
48 min
8. Gastric cancer, gastritis and the role of H. pylori- Prof. Anthony Axon
-
48 min
9. Celiac disease- Prof. Ciaran Kelly
-
43 min
10. IBD for the non-gastroenterologist- Prof. Sunanda Kane
-
34 min
11. The enteric microbiota in health and disease- Dr. Francisco Guarner
-
45 min
12. Colorectal cancer and hereditary colon cancer syndromes- Prof. Carol A. Burke
-
39 min
13. The spectrum of GI ischemia 1- Prof. Lawrence J. Brandt
-
31 min
14. The spectrum of Gl ischemia 2- Prof. Lawrence J. Brandt
-
41 min
15. Constipation and defecation disorders- Prof. Satish S. C. Rao
-
40 min
16. Diverticular disease of the colon- Dr. Dale Vimalachandran
-
73 min
17. Irritable bowel syndrome (IBS)- Prof. Eamonn M. M. Quigley
-
27 min
18. Evidence-based management of non-variceal upper GI bleeding- Prof. Joseph J. Sung
- Hepatology
-
32 min
19. Hepatitis B virus (HBV)- Prof. Marco Olivera-Martinez
-
26 min
20. Hepatitis C - cure of infection- Prof. Mark Mailliard
-
46 min
21. Drug-induced liver injury: importance, epidemiology, and mechanisms of DILI- Prof. James H. Lewis
-
26 min
22. Drug-induced liver injury: risk factors and drug development in DILI- Prof. James H. Lewis
-
39 min
23. Drug-induced liver injury: HDS, diagnosing, treating and preventing DILI- Prof. James H. Lewis
-
22 min
24. Portal hypertension- Prof. John Reinus
-
55 min
25. Portal hypertension: at the bedside- Dr. Clara Y. Tow
-
29 min
26. The management of chronic liver disease, including transplantation 1- Prof. Timothy M. McCashland
-
21 min
27. The management of chronic liver disease, including transplantation 2- Prof. Timothy M. McCashland
-
34 min
28. Hereditary hemochromatosis: what have we learnt from population studies- Prof. John K. Olynyk
-
38 min
29. Immune-mediated liver disease- Dr. Jenny Heathcote
-
51 min
30. Alcoholic liver disease- Prof. Michael Lucey
- The Pancreas and Biliary Tree
-
51 min
31. Acute pancreatitis- Prof. Davor Štimac
-
49 min
32. Chronic pancreatitis- Prof. Christopher Forsmark
-
47 min
33. Pancreatic cancer- Prof. Randall Brand
-
20 min
- Archived Lectures *These may not cover the latest advances in the field
-
52 min
35. The management of other aspects of chronic liver disease, including transplantation- Prof. Timothy M. McCashland
-
38 min
36. Chronic viral hepatitis B and C- Prof. Mark Mailliard
-
41 min
37. Pancreatic cancer- Prof. Randall Brand
-
72 min
38. Acute viral hepatitis- Prof. Geoffrey Dusheiko
-
33 min
39. Diverticular disease- Dr. Charles Knowles
-
57 min
40. The spectrum of gastrointestinal ischemia: 2010- Prof. Lawrence J. Brandt
Printable Handouts
Navigable Slide Index
- Introduction
- Professor Anthony Axon
- Incidences and mortality of cancer types
- Scanning EM of Helicobacter pylori
- Aims of this presentation
- Transmission EM of Helicobacter pylori
- Acute infection with H. pylori
- Biopsies of acute gastric inflammation
- Chronic gastritis with "activity" in the antrum
- Helicobacter gastritis before and after treatment
- H. pylori gastric mucosa interactions
- Atrophy and intestinal metaplasia after infection
- H. pylori, gastric atrophy and IM over time
- Natural history of Hp Gastritis
- Hp as an essential risk factor for gastric cancer
- Association between Hp and gastric cancer
- Problems with IgG ELISA serology
- Gastric cancer and Hp - corrected for CagA
- Helicobacter gastritis and gastric acidity (1)
- Type of gastritis and cancer risk
- Corpus atrophy in gastric cancer
- Conclusive flow chart
- H. pylori infection in animal models
- H. pylori and gastric cancer - summary
- Mechanisms involved in gastric carcinogenesis
- Does Hp itself directly cause gastric cancer?
- The Correa hypothesis
- Epithelial cell proliferation and Hp eradication
- Gastric ascorbic acid conc. and Hp eradication
- Reactive oxygen species in H, pylori gastritis
- Effect of treatment
- Stem cells
- Bone marrow derived cells
- Bone marrow derived cells and gastric cancer
- New model for gastric cancer development
- Appreciate why gastric cancer incidence varies
- World map of gastric cancer mortality
- Why does gastric cancer vary in incidence?
- Hp and the socio-economically disadvantaged
- Japanese versus British gastritis
- Comparison of gastritis in matched populations
- IM and atrophy in matched populations
- Differing gastritis patterns in Japan and England
- Difference in diet
- Dietary factors influence on gastric cancer
- Effects of the CagA pathogenicity island
- Non-cardia cancer and Hp genotypes
- Genetics and gastric cancer
- Proinflammatory cytokine gene polymorphisms
- Hp and host genetics and carcinogenic effects
- Helicobacter gastritis and gastric acidity (2)
- Inflammation in the corpus and acid secretion
- Corpus atrophy after acid suppression treatment
- Increasing acid secretion in Japan
- Acid secretion is related to lean body mass
- Increasing height of men in Europe 1960-1990
- Immune experience
- Summary
Topics Covered
- Helicobacter pylori (Hp) and gastric cancer
- Natural history of Hp gastritis
- Hp as an essential risk factor
- Mechanisms of carcinogenesis
- Why the variation in cancer incidence?
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Axon, A. (2011, May 9). Gastric cancer, gastritis and the role of H. pylori [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 19, 2024, from https://hstalks.com/bs/1905/.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Anthony Axon has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Gastric cancer, gastritis and the role of H. pylori
Published on May 9, 2011
48 min
